Last $3.72 USD
Change Today -0.01 / -0.27%
Volume 58.6K
FHCO On Other Exchanges
Symbol
Exchange
Berlin
As of 10:12 AM 09/22/14 All times are local (Market data is delayed by at least 15 minutes).

female health company (FHCO) Snapshot

Open
$3.73
Previous Close
$3.73
Day High
$3.74
Day Low
$3.67
52 Week High
10/3/13 - $9.98
52 Week Low
09/8/14 - $3.60
Market Cap
107.5M
Average Volume 10 Days
154.8K
EPS TTM
$0.33
Shares Outstanding
28.9M
EX-Date
07/14/14
P/E TM
11.3x
Dividend
--
Dividend Yield
5.65%
Current Stock Chart for FEMALE HEALTH COMPANY (FHCO)

female health company (FHCO) Related Bloomberg News

View More Bloomberg News

female health company (FHCO) Related Businessweek News

No Related Businessweek News Found

female health company (FHCO) Details

The Female Health Company manufactures, markets, and distributes consumer health care products. It offers the FC2 female condom that provides women dual protection against unintended pregnancy and sexually transmitted infections, including HIV/AIDS; and male condoms. The company sells its products to global agencies, non-government organizations, ministries of health, and other government agencies directly, as well as through distribution agreements and other arrangements with commercial partners. It operates in South Africa, Brazil, Uganda, Nigeria, the United States, the Democratic Republic of the Congo, and internationally. The company was founded in 1896 and is headquartered in Chicago, Illinois.

132 Employees
Last Reported Date: 12/3/13
Founded in 1896

female health company (FHCO) Top Compensated Officers

Founder and Chairman
Total Annual Compensation: $273.2K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $202.8K
Vice President, Secretary and Director
Total Annual Compensation: $19.0K
Consultant and Director
Total Annual Compensation: $56.7K
Consultant
Total Annual Compensation: $227.0K
Compensation as of Fiscal Year 2013.

female health company (FHCO) Key Developments

The Female Health Company Announces Executive Changes, Effective September 15, 2014

The Female Health Company announced that Martin Tayler will join the company's management team as Executive Vice President of Global Operations effective September 15, 2014. The company also announced that Michael Pope will retire from his position as Vice President, U.K. and Malaysian Operations, effective September 15, 2014. Following his retirement, Mr. Pope will continue his affiliation with the Company as a Consultant. Prior to joining The Female Health Company (FHC), Mr. Tayler had an extensive career in medical device operations leadership with SSL International PLC.

The Female Health Company Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended June 30, 2014

The Female Health Company announced unaudited consolidated earnings results for the third quarter and nine months ended June 30, 2014. For the quarter, the company reported net revenue of $7,900,055 against $7,280,498 a year ago. Operating income was $2,027,630 against $1,089,896 a year ago. Income before income taxes was $2,010,819 against $1,055,849 a year ago. Net income was $1,159,498 against $726,911 a year ago. Net income per basic common share outstanding was $0.04 against $0.03 a year ago. For the nine months, the company reported net revenue of $18,936,473 against $26,667,591 a year ago. Operating income was $4,406,489 against $8,047,617 a year ago. Income before income taxes was $4,454,276 against $8,223,410 a year ago. Net income was $2,999,182 against $7,752,426 a year ago. Net income per diluted common share outstanding was $0.10 against $0.27 a year ago. During the first nine months the company generated positive cash flow from operations of approximately $1.5 million, including a negative impact related to changes in operating assets and liabilities of $3.4 million.

Female Health Company Seeks Acquisitions

The Female Health Company (NasdaqCM:FHCO) is seeking acquisitions. The Female Health Company will pursue the acquisition of a new product, technology and/or business that is complementary to FC2 in market segment, product category or channel presence.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FHCO:US $3.72 USD -0.01

FHCO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for FHCO.
View Industry Companies
 

Industry Analysis

FHCO

Industry Average

Valuation FHCO Industry Range
Price/Earnings 11.2x
Price/Sales 4.5x
Price/Book 3.7x
Price/Cash Flow 11.2x
TEV/Sales 4.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FEMALE HEALTH COMPANY, please visit www.femalehealth.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.